Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Add abstracts to 35 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact35 DOIs

Attach ORCID iDs across 32 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact32 DOIs

Deposit reference lists for 30 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact30 DOIs

DOIs for this ISSN

Showing the top 5 of 138 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Chikungunya Fever Outbreak in Foshan, China: Lessons in Earl… (10.1002/ila2.70035)	Abstract	11.93	2
2	The Potential of Blood KIM‐1 as a Biomarker in Early Diagnos… (10.1002/ila2.71)	Abstract	11.93	2
3	Focus on lipoprotein(a): The time is now (10.1002/ila2.19)	Abstract	7.53	1
4	The incidence of liver abnormalities is higher in inactive h… (10.1002/ila2.20)	Abstract	7.53	1
5	The important role of skin biopsies in the diagnosis of mpox (10.1002/ila2.29)	Abstract	7.53	1
6	Issue Information (10.1002/ila2.1)	References ORCID	0.00	0
7	Comparison of an automated digital cell morphology analysis… (10.1002/ila2.10)		0.00	0
8	Bottlenecks and recent advancements in detecting <i>Mycobact… (10.1002/ila2.11)		0.00	10
9	Single cell metabolic phenome and genome via the ramanome te… (10.1002/ila2.12)		0.00	3
10	Interim proposal for collecting and handling of microbiology… (10.1002/ila2.13)	Abstract	0.00	0
11	Issue Information (10.1002/ila2.14)	References ORCID	0.00	0
12	Issue Information (10.1002/ila2.15)	References ORCID	0.00	0
13	Issue Information (10.1002/ila2.16)	References ORCID	0.00	0
14	Issue Information (10.1002/ila2.17)	References ORCID	0.00	0
15	Application of autoantibody detection in chronic liver disea… (10.1002/ila2.18)		0.00	0
16	Issue Information (10.1002/ila2.2)	References ORCID	0.00	0
17	An iASPP‐derived short peptide restores p53‐mediated cell de… (10.1002/ila2.21)		0.00	1
18	The mechanism of copper homeostasis and its role in disease (10.1002/ila2.22)		0.00	19
19	Clinical utility of six serum tumor markers for the diagnosi… (10.1002/ila2.23)		0.00	11
20	Significant histological changes are not rare in indetermina… (10.1002/ila2.24)		0.00	1
21	Investigating Torsin‐1A‐interacting protein 1 as a predictiv… (10.1002/ila2.25)		0.00	0
22	Mutating <i>Escherichia coli</i> caused multiple organ dysfu… (10.1002/ila2.26)		0.00	0
23	Overview of the epidemic characteristics of <i>Mycoplasma pn… (10.1002/ila2.27)		0.00	7
24	Clinical validation of serum immunosignatures in early diagn… (10.1002/ila2.28)		0.00	0
25	Issue Information (10.1002/ila2.3)	References ORCID	0.00	0
26	Identification of new diagnostic targets for hepatitis B vir… (10.1002/ila2.30)		0.00	0
27	Biomarkers for predicting efficacy of chimeric antigen recep… (10.1002/ila2.31)		0.00	3
28	Successful treatment of severe monkeypox case with advanced… (10.1002/ila2.32)		0.00	1
29	From bench to bedside: Opportunities and challenges for <i>i… (10.1002/ila2.33)		0.00	1
30	A preliminary study of the mechanism of compound hearing los… (10.1002/ila2.34)		0.00	3
31	<i>Pseudomonas aeruginosa</i> infections and improper storag… (10.1002/ila2.35)		0.00	1
32	Diagnostic approaches for monkeypox virus (10.1002/ila2.36)		0.00	13
33	Differences in the system accuracy acceptability of four typ… (10.1002/ila2.37)		0.00	1
34	Clinical characteristics and risk factors for mortality in <… (10.1002/ila2.38)		0.00	3
35	Candidate reference measurement procedure for serum 17‐hydro… (10.1002/ila2.39)		0.00	0
36	Concomitant and sequential administration of nirmatrelvir‐ri… (10.1002/ila2.40)		0.00	2
37	The exploration of cell population data in clinical use: Bey… (10.1002/ila2.41)		0.00	4
38	Issue Information (10.1002/ila2.42)	References ORCID	0.00	0
39	Issue Information (10.1002/ila2.43)	References ORCID	0.00	0
40	Bridging the divide: Harmonizing polarized clinical laborato… (10.1002/ila2.46)	Abstract ORCID	0.00	0
41	Hypermethylation of <i>GSTM5</i> and its effect on oxidation… (10.1002/ila2.47)		0.00	1
42	A case of central nervous system infection with <i>Scedospor… (10.1002/ila2.48)		0.00	0
43	Accuracy evaluation of Roche Accu‐Chek Performa blood glucos… (10.1002/ila2.49)		0.00	3
44	<i>iLABMED</i>, why now and how in the future? (10.1002/ila2.5)		0.00	0
45	Clinicopathological and prognostic role of CEP55 expression… (10.1002/ila2.50)		0.00	1
46	Dye‐based recombinase‐aided amplification assay with enhance… (10.1002/ila2.51)		0.00	1
47	A predictive model for ischemic colitis: Integrating clinica… (10.1002/ila2.52)		0.00	0
48	Correction to “The exploration of cell population data in cl… (10.1002/ila2.53)	Abstract References ORCID	0.00	0
49	Rapid development of neurological infection in a patient wit… (10.1002/ila2.54)		0.00	1
50	RT‐PCR in the early detection and monitoring of pathogen res… (10.1002/ila2.55)		0.00	2